HomeHealthcare and Life Sciences North America Actinic Keratosis Treatment Market

North America Actinic Keratosis Treatment Market Size, Share, Growth, and Industry Analysis, By Treatment Type (Topical Therapies, Cryotherapy, Photodynamic Therapy), By End User (Hospitals, Dermatology Clinics, Homecare Settings), Regional Insights and Forecast to 2034

Report Code: SMI1234PUB | Last Updated : 08 July, 2026 | Base Year : 2025 | Historical Data : 2022-2024 | Region : North America | Format : PDF, Excel | Number of Pages : 140 | Author : Jenny Burkett

Table of Contents

  1. Executive Summary
    1. Introduction
  2. Market Introduction
    1. Market Definition
    2. Scope of the Study
    3. Market Structure
  3. Research Methodology
    1. Primary Research
    2. Research Methodology
    3. Assumptions & Exclusions
    4. Secondary Data Sources
  4. Market Factor Analysis
    1. Value Chain Analysis: North America Actinic Keratosis Treatment Market
    2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
  6. Recent Trends Analysis
  7. Impact of COVID-19 on North America Actinic Keratosis Treatment Market
    1. Pre and Post Covid -19 Market Scenario Analysis
    2. Market Recovery Timeline and Challenge
    3. Measures Taken by Top Players
  8. Regulatory Landscape
  9. North America Actinic Keratosis Treatment Market, Treatment Type
    1. Introduction
      1. Market Size and Forecast, Treatment Type
    2. Topical Therapies
      1. Market Size and Forecast, By Region
    3. Cryotherapy
      1. Market Size and Forecast, By Region
    4. Photodynamic Therapy
      1. Market Size and Forecast, By Region
  10. North America Actinic Keratosis Treatment Market, End User
    1. Introduction
      1. Market Size and Forecast, End User
    2. Hospitals
      1. Market Size and Forecast, By Region
    3. Dermatology Clinics
      1. Market Size and Forecast, By Region
    4. Homecare Settings
      1. Market Size and Forecast, By Region
  11. Regional Overview
    1. Introduction
      1. Market Size and Forecast
    2. North America
      1. Market Size and Forecast
        1. Treatment Type
          1. Topical Therapies
            1. Cryotherapy
              1. Photodynamic Therapy
              2. End User
                1. Hospitals
                  1. Dermatology Clinics
                    1. Homecare Settings
                  2. U.S.
                    1. Treatment Type
                      1. Topical Therapies
                        1. Cryotherapy
                          1. Photodynamic Therapy
                          2. End User
                            1. Hospitals
                              1. Dermatology Clinics
                                1. Homecare Settings
                              2. Canada
                          3. Competitive Landscape, 2025
                            1. Introduction
                            2. North America Actinic Keratosis Treatment Market Share Analysis, 2025 (%)
                              1. Market Share Analysis, 2025
                              2. Competition Ranking, 2025
                              3. Key Developments & Growth Strategies
                                1. Merger & Acquisition
                                2. Product Launch
                                3. Expansion
                              4. Consolidated SWOT Analysis of Key Players
                          4. Company Profile
                            1. Almirall SA
                              1. Business Overview
                              2. Financial Data
                              3. Key Product domains
                              4. Recent Developments
                            2. Sun Pharmaceutical Industries Ltd.
                            3. LEO Pharma A/S
                            4. Bausch Health Companies Inc.
                            5. Novartis AG
                            6. Pfizer Inc.
                            7. Galderma SA
                            8. AbbVie Inc.
                            9. Mylan N.V.
                            10. 3M Company
                            11. Biofrontera AG
                            12. Amgen Inc.
                            13. Eli Lilly and Company